Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleMINIMAL RESIDUAL DISEASE AND OUTCOMES IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) IN THE PHASE III GADOLIN TRIAL OF OBINUTUZUMAB AND BENDAMUSTINE VS BENDAMUSTINE.AuthorsPott, C.; Belada, D.; Danesi, N.; Fingerle ‐ Rowson, G.R.; Gribben, J.; Harbron, C.G.; Hoster, E.; Kahl, B.S.; Kehden, B.; Mundt, K.E.; Nicolas ‐ Virelizier, E.; Sehn, L.H.; Cheson, B.D.PublicationHematological Oncology, 2017, Vol 35, p216ISSN0278-0232Publication typeArticleDOI10.1002/hon.2438_80